phase ii study of ne3107 in levodopa/carbidopa-treated patients with parkinson's disease
Published 1 year ago • 125 plays • Length 2:20Download video MP4
Download video MP3
Similar videos
-
1:13
extending the efficacy of levodopa in patients with parkinson’s disease
-
4:07
phase ii study of ne3107 in degenerative dementias
-
2:35
levodopa dose adjustment versus adjunctive therapy in parkinson’s disease
-
0:50
subcutaneous levodopa/carbidopa infusion for parkinson's disease
-
2:37
long-term effectiveness of levodopa-carbidopa intestinal gel in parkinson's disease
-
3:32
adequately treating parkinson disease with levodopa
-
9:31
challenges faced in early parkinson’s disease management and the resurgence of levodopa
-
2:31
phase ii study of risvodetinib in parkinson's disease
-
1:27
updates on levodopa infusion therapies for advanced parkinson’s disease
-
2:11
the parkinson's minute: gel formulation of levodopa-carbidopa
-
1:13
the elegance study: levodopa-entacapone-carbidopa intestinal gel in parkinson's disease
-
3:31
nd0612 vs oral immediate-release levodopa/carbidopa in patients with pd and motor fluctuations
-
31:56
parkinson's disease treatment pipeline
-
2:32
latest approaches to improve the delivery of levodopa
-
0:50
benefits of combining levodopa with carbidopa in parkinsonism
-
6:18
my parkinson's body & timing when to take levodopa/carbidopa
-
3:17
carbidopa and levodopa for parkinson's disease
-
6:30
pharmacology - parkinson's disease
-
3:02
improvements to levodopa-based treatments for parkinson’s disease